TrialThe New England journal of medicine2007
Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
Claus M Larsen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
864 papers cite itlatest 60 shown
this paperpooled ittrialcites it